Sunrakshakk Industries India Limited Overview
Sunrakshakk Industries India Limited is a Bhilwara-based micro-cap that is in the middle of a fast transformation. For about three decades, as A.K. Spintex, it ran a job-work process house that dyed, printed and finished polyester and cotton grey fabric for the Bhilwara textile cluster, with revenue around ₹50–120 crore. In December 2024 it acquired a related-party business, Sunrakshak Agro Products Pvt. Ltd., and changed its name. It then raised about ₹98.65 crore through a preferential issue and used it to acquire manufacturing assets in Bhilwara (edibles) and Guwahati (soap noodles and cosmetics). The company is now mainly a B2B contract and intermediate manufacturer of soap noodles, toilet soaps, detergents, toothpaste, cosmetics, home-care products and packaged savouries/spices. It runs five FMCG plants and one fabric plant across Rajasthan, Uttarakhand and Assam. FY2026 consolidated revenue was ₹607.75 crore, up 237% year on year. Q1 FY27 revenue was ₹276.33 crore, of which about 90.6% came from FMCG. Management targets about ₹1,000 crore of revenue by FY2028.
What the company does
The company now has two operating businesses. Third-party profiles such as Simply Wall St also describe two segments, "Textiles" and "FMCG".
-
Textile processing (legacy). The company processes synthetic (polyester) and cotton grey fabric, including dyeing, printing and finishing, mostly on a job-work basis. That means the customer, typically a weaver or fabric trader in the Bhilwara cluster, owns the grey fabric and pays a processing charge. The finishing range includes a Comfit finish range and a fully automatic Yamuna hydraulic jigger (both added in FY2015) and a set brushing/sueding machine (added in FY2017). Disclosed processing capacity is 45 lakh metres per month (company investor deck). CRISIL's rationale cites 48 lakh metres per month from older information. Processed volume in FY2026 was 5.10 crore metres (Q1 FY27 deck).
-
FMCG, FMCG intermediates and edibles (new since Jan 2025). This business manufactures:
-
FMCG intermediates: mainly soap noodles, the base input that soap brands buy and then perfume, mill and stamp into bars.
-
Personal care: toilet/bath soap, toothpaste and cosmetics.
-
Home care: detergent powder/bars, cleaners and other home-care products. Plastic moulding products are also mentioned in the Q2 FY26 deck.
-
Edibles: savouries (Sun Papsi, Majedar Bhujia, coated peanuts, packed ghee) and spices (Rasoi Tadaka Masala, red chilli, turmeric and coriander powders).
-
Business model and revenue model
| Dimension | Characterisation |
|---|---|
| Product vs. service mix | Textile: a service model (job-work processing fees). FMCG: a product model (manufactured goods sold B2B). Edibles: products, some under in-house names. |
| Subscription / licensing | — |
| B2B vs. B2C | On the Q1 FY27 call (Aug 2026), management said revenue is "basically B2B" and the company does not operate in B2C. Edible SKUs carry names such as "Sun Papsi", but the company does not describe itself as running a consumer brand business. |
| Customer count | 200+ customers (Q2 FY26 and Q1 FY27 decks) |
| Customer types | Textile: Bhilwara-cluster weavers, fabric traders and suiting/shirting converters. FMCG: soap and detergent brand owners, FMCG marketers and distributors. Edibles: distributors and retail channels. No customers are named publicly. |
| End-markets | Domestic Indian textiles (suiting/shirting fabrics); Indian FMCG (personal care, home care); packaged foods |
| Geography | Essentially India only. No export revenue is disclosed. |
Value-chain position
In textiles, the company sits in the mid-stream processing stage, between weaving and garmenting. It earns a conversion margin and carries limited raw-material risk because it does not own the fabric, although it does buy dyes, chemicals and boiler fuel. In FMCG, it sits upstream of consumer brands. As a soap-noodle supplier it is a chemical-intermediate converter, buying oils/fatty acids and caustic soda. As a finished-goods contract manufacturer it competes on cost, capacity and proximity to customers' markets. This position gives lower gross margins than branded FMCG players, but it needs less spending on advertising and distribution.
The company's own description and independent characterisation
In its 22 May 2025 press release and FY2026 Annual Report, the company describes itself as a diversified enterprise. It says textiles remain an important foundation, while future growth is anchored in FMCG and FMCG-intermediate chemicals. The FY2026 chairman's letter says FMCG contributed about 82% of FY2026 revenue, compared with 42% in FY2025, and that FMCG revenue crossed ₹500 crore.
Independent characterisation: In substance, Sunrakshakk is now a small-ticket B2B FMCG contract and intermediate manufacturer, with a legacy textile job-work unit attached. Its economics look more like a B2B manufacturing platform such as Hindustan Foods (EBITDA margin around 8–9%) than like a branded FMCG company such as Jyothy Labs (operating margin around 13–14%). Q1 FY27 consolidated EBITDA margin was 8.18%, and FMCG segment EBITDA margin was 8.55%. Growth has come mainly from acquiring and commissioning capacity: SAPPL, the Bhilwara food facility, the Guwahati plant and the Roorkee soap line. The investment case now rests on raising utilisation from the current 50–55%, and on whether management can keep margins steady through crude-linked input volatility.
Strategy
Stated strategy themes (paraphrased from FY2026 Annual Report and investor decks)
Change the revenue mix toward FMCG: Make FMCG, FMCG intermediates and edibles the growth engine, with textile falling to about 8–10% of revenue over the long term (Q1 FY27 concall).
- Scale through acquired and commissioned capacity, then sweat the assets. Capacity build-out is largely complete. Management does not expect much incremental capacity capex for the next 12–18 months, and the focus moves to raising utilisation from 50–55% (Q1 FY27 concall).
Build a multi-location manufacturing network: Plants in Bhilwara (West/North), Roorkee (North) and Guwahati (East/North-East) aim to cut freight costs and add supply-chain flexibility.
Deepen distribution and channels; optimise manufacturing: This is the "Way Ahead" slide of the Q4 FY26 deck.
Allocate capital prudently: No new fundraise is planned. The company intends to keep working capital from scaling in proportion to revenue.
Strategic initiatives in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Amend objects for the FMCG foray | Oct 2024 | MoA amended to cover cosmetics, personal/home/plant/pet care, packaging and intermediates | Done |
| SAPPL acquisition | 27 Dec 2024 | 100% of a related-party FMCG/intermediates maker | Integrated; consolidated from 1 Jan 2025 |
| Rebranding | Apr–May 2025 | Name change, scrip ID change, website migration (Feb 2026) | Done |
| Preferential equity raise | Mar–Jul 2025 | 11,69,600 shares at ₹840 (about ₹98 crore) | Allotted 30 May 2025 |
| Bhilwara food facility acquisition | 2,025 | Savouries and spices; fully operational Sep 2025 | Ramping; single shift |
| Guwahati plant acquisition and commissioning | Late 2025 → 8 Jan 2026 | Soap noodles 2,160 TPM plus cosmetics 1,000 TPM | Ramping (₹63.9 crore in Q1 FY27) |
| Roorkee soap line | Q1 FY27 | +1,700 TPM toilet soap | Commissioned |
| Stock split | Oct 2025 | 1:5, to improve liquidity | Done |
| Investor communication programme | Jun 2025 onward | Quarterly decks and earnings calls with recordings | Ongoing |
Management targets and guidance
| Target | Source / date | Detail |
|---|---|---|
| Revenue about ₹1,000 crore by FY2028 | Q2 FY26 deck (Nov 2025); reiterated through Q1 FY27 | About 90% from FMCG |
| Revenue CAGR 30–35% over FY2025–FY2029 | Q2 FY26 / Q4 FY26 decks | Directional |
| FY2027 revenue ₹900–1,000 crore | Q1 FY27 concall (Aug 2026) | This pulls the ₹1,000 crore aspiration forward by about a year |
| FY2028 revenue growth of 15–20% over FY2027 | Q1 FY27 concall | Implies about ₹1,035–1,200 crore |
| PAT margin about 6% in FY2027, improving 0.75–1.0 pp in FY2028 | Q1 FY27 concall | An earlier deck cited 7% PAT margin by FY2028 |
| Return on capital deployed 28–30% (run-rate) | Q4 FY26 / Q1 FY27 decks | Company's own calculation on ₹98.65 crore raised |
| No fresh fundraise | Q1 FY27 concall | Current stance |
ESG or sustainability commitments: none disclosed. Formal cost programmes: none disclosed.
Products & Services
Textile segment
| Offering | Description / specifications | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|
| Polyester fabric processing | Dyeing and finishing of synthetic grey fabric (suiting/shirting) on job-work | Bhilwara weavers and traders | Since 1995 | Per-metre job-work charge (rates not disclosed) |
| Cotton fabric processing | Dyeing, printing and finishing of cotton grey fabric | Same | Since 1995 | Job-work |
| Printing | Fabric printing services | Same | — | Job-work |
| Value-added finishes | Comfit finish (FY2015), hydraulic jigger dyeing (FY2015), sueding/brushing (FY2017) | Premium suiting converters | FY2015–FY2017 | Job-work |
| Capacity | 45 lakh metres/month (company); 48 lakh m/month (CRISIL, older data) | — | — | — |
| Volume | 5.10 crore metres processed in FY2026 | — | — | — |
FMCG intermediates
| Product | Plant | Monthly capacity (MT) | Description | Customer | Status |
|---|---|---|---|---|---|
| Soap noodles | Roorkee | 5,760 | Base soap pellets for toilet and laundry soap makers; the largest revenue line (₹87.62 crore in Q1 FY27) | Soap brand owners and contract soap makers | Operating |
| Soap noodles | Guwahati | 2,160 | Same; serves the North-East and eastern markets | Same | Commissioned 8 Jan 2026 |
FMCG finished products (personal and home care)
| Product | Plant | Monthly capacity (MT) | Notes |
|---|---|---|---|
| Toilet/bath soap | Roorkee | 3,000 (+1,700 new line in Q1 FY27) | ₹27.50 crore revenue in Q1 FY27. The website lists "Bath Soap" as a focus product. |
| Toothpaste | Roorkee | 500 | Listed as a new business vertical in the Q2 FY26 deck |
| Cosmetics / personal care | Guwahati | 1,000 | ₹26.15 crore revenue in Q1 FY27 |
| Detergent (powder/bar) | Bhilwara | 3,500 | Detergent bars were a core SAPPL line at acquisition |
| Home care (cleaners etc.) | Bhilwara | 1,200 | ₹3.49 crore in Q2 FY26 per deck |
| Plastic moulding products | — | — | Mentioned in the Q2 FY26 deck and in Simply Wall St's profile |
Edibles
| Category | Named SKUs (per Q4 FY26 deck) | Plant / capacity | Commissioned |
|---|---|---|---|
| Savouries | Sun Papsi; Majedar Bhujia; coated peanuts; ghee (pack) | Bhilwara; savouries 850 TPM (total edibles 2,500 TPM) | Fully operational Sep 2025 |
| Spices | Rasoi Tadaka Masala; red chilli powder; turmeric powder; coriander powder | Bhilwara; spices 650 TPM | Sep 2025 |
The edibles plant runs one shift, and management has said a second shift is available, giving room to grow without new capex (Q1 FY27 concall). Pricing is not disclosed for any product line.
Aggregate capacity
| Capacity metric | Q2FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|
| FMCG and intermediates capacity (MT per month) | 15,480 | 19,640 | 20,840 |
| Textile processing capacity (lakh metres per month) | 45 | 45 | 45 |
Note: the section-wise capacities sum to 19,620 MT before the new soap line. Adding 1,700 MT should give about 21,320 MT, but the company reports 20,840 MT. This gap of about 480 MT has not been explained. Overall utilisation is 50–55% (Q1 FY27 concall).
Financial Narrative
FY2022–FY2024 are standalone (pure textile). FY2025 consolidates one quarter of SAPPL. FY2026 is the first full consolidated year. Sources: Screener.in (C-MOTS data from BSE filings); company investor decks for FY2025 and FY2026 revenue, EBITDA and PAT; CRISIL KFI table for FY2026. Screener rounds to whole crores, so ratios computed from those figures are approximate.
Income statement (INR crore)
Diluted EPS equals basic EPS because no convertibles are disclosed.
Margins (%)
Revenue CAGR FY2022–FY2026: about 70% ((607.75/73)^(1/4) − 1). Excluding acquisition effects, the textile business grew from ₹73 crore to about ₹109 crore, a CAGR of about 10%.
Commentary.
FY2023 was the first inflection: Textile revenue jumped 59% as post-COVID cluster demand recovered, and EBITDA margin expanded 400 bps to 14% on operating leverage.
FY2024: was flat on revenue (₹117 crore), but EBITDA margin rose to 16% as costs eased.
FY2025: contains a textile decline to about ₹104.5 crore, offset by ₹75.7 crore of FMCG revenue from one quarter of SAPPL.
FY2026 is the transformation year: Revenue more than tripled, but EBITDA margin compressed to 9.66% because the mix shifted to lower-margin B2B FMCG. Management explicitly says FY2026 ratios are not comparable with FY2025.
Quarterly EBITDA margin then ran at 9.28% (Q1 FY26), 9.65% (Q2), 9.31% (Q3), 10.19% (Q4) and 8.18% (Q1 FY27). The Q1 FY27 dip reflected crude-linked raw-material inflation (LABSA, dyes, chemicals, boiler fuel). Gross profit is not separately disclosed in the sources reviewed.
Quarterly trajectory (consolidated, INR crore)
Q2 FY26 EBITDA is derived as FY2026 total minus the other three quarters. Q2 and Q3 PAT are derived from Google Finance EBT and tax data and reconcile to the FY2026 total of ₹34.98 crore. Company decks report Q1 FY26 EPS as ₹2.41, while Screener shows ₹2.10, because of different share-count bases. TTM to Q1 FY27: revenue about ₹759 crore and PAT about ₹43.5 crore (Screener).
Balance sheet (INR crore, as at 31 March)
Net debt cannot be computed precisely because year-end cash is not disclosed in the sources reviewed. Aggregator data suggests cash is small, in the single-digit crores. On that basis, net debt in FY2026 is probably close to gross debt of about ₹47 crore. Goodwill from the SAPPL acquisition is not separately disclosed in the sources reviewed.
Commentary. The balance sheet stayed tiny and conservative through FY2024, with debt/equity of 0.18. FY2025 shows the acquisition footprint. Standalone investments rose from ₹0 to ₹25 crore, which is consistent with the cost of acquiring SAPPL, although the exact consideration is not disclosed. Standalone borrowings rose from ₹7 crore to ₹41 crore, which suggests the deal was largely debt-funded; this is an inference. In FY2026 the preferential issue of about ₹98 crore lifted reserves from ₹47 crore to ₹179 crore. That capital went into fixed assets (up ₹40 crore) and, more significantly, into working capital (other assets up ₹122 crore).
Cash flow (INR crore)
Commentary. Cash conversion is the most important red flag in the financial profile. The textile business historically converted 84–128% of EBITDA into operating cash, helped by negative cash-conversion cycles because it held customer fabric and paid suppliers slowly. After the FMCG pivot, CFO collapsed to roughly zero in FY2025 and to −₹34 crore in FY2026, despite ₹58.7 crore of EBITDA. Standalone CFO was −₹66 crore. The cumulative two-year FCF deficit of about ₹113 crore was financed by the preferential issue and new debt. Screener also flags that the company "might be capitalising interest cost". Management says it intends to keep working capital from rising in proportion to revenue. Proof of that would be the main validation event for FY2027.
Ratios
ROE, ROA and asset turnover are computed on average balances from rounded Screener figures. ROCE and working-capital metrics are Screener-reported (standalone FY2022–FY2024, consolidated FY2025–FY2026). Interest is rounded to ₹1 crore in early years, so coverage ratios are indicative only. Net debt/EBITDA is shown as gross debt/EBITDA because cash is not disclosed.
Commentary. Returns are high on paper: about 30% ROE and 29% ROCE in FY2026. However, they sit alongside negative operating cash flow, which points to earnings that are not yet backed by cash. The cash-conversion cycle swung from −40 days to +31 days. Payable days collapsed from 264 to 72, so the supplier credit that funded the textile business is not available in FMCG, where commodity inputs are bought on short terms. At standalone level, working-capital days ballooned from 22 to 161. Leverage is low (0.25x D/E; about 0.8x debt/EBITDA), and interest cover is comfortable at about 15x.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Business | Notes |
|---|---|---|---|
Sunrakshakk Industries India Ltd | Listed parent | Textile processing (Bhilwara); also owns the Bhilwara edibles facility and the Guwahati plant, both acquired with preferential-issue proceeds | Standalone FY2026 revenue ₹214 crore |
Sunrakshak Agro Products Pvt. Ltd. (SAPPL) | Wholly owned subsidiary since 27 Dec 2024 | FMCG products and intermediate chemicals (detergent bars, home care, personal care, soap noodles) | Authorised capital ₹2 crore. Consolidation adds about ₹394 crore of FY2026 revenue (consolidated ₹608 crore minus standalone ₹214 crore). |
Revenue by Segment and Revenue by Segment (%)
| Segment | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Textile processing revenue (INR Cr) | 117 | 104.5 | 109 |
FMCG incl. intermediates and edibles revenue (INR Cr) | 0 | 75.7 | 498 |
Total revenue from operations (INR Cr) | 117 | 180.16 | 607.75 |
Textile share of revenue (%) | 100 | 58 | 18 |
FMCG share of revenue (%) | 0 | 42 | 82 |
Revenue by Segment
| Segment | Q4FY26 | Q1FY27 |
|---|---|---|
FMCG revenue (INR Cr; Q4FY26 label-corrected) | 170.79 | 250.10 |
Textile revenue (INR Cr; Q4FY26 label-corrected) | 26.80 | 26.23 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment by Location / Section
| Location / section | Q4FY26 | Q1FY27 |
|---|---|---|
Roorkee soap section (INR Cr) | 17.63 | 27.50 |
Roorkee noodle section (INR Cr) | 44.47 | 87.62 |
Bhilwara home care and detergent (INR Cr) | 32.50 | 40.98 |
Bhilwara edibles (INR Cr) | 29.26 | 30.34 |
Guwahati cosmetics (INR Cr) | 20.91 | 26.15 |
Guwahati noodle section (INR Cr) | 26.01 | 37.75 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 73 | 116 | 117 | 180.16 | 607.75 |
EBITDA (INR Cr) | 7 | 16 | 19 | 25.66 | 58.69 |
Depreciation (INR Cr) | 4 | 6 | 7 | 11 | 14 |
Operating income EBIT approx (INR Cr) | 3 | 10 | 12 | 15 | 45 |
Other income (INR Cr) | 0 | 0 | 0 | 1 | 3 |
Interest expense (INR Cr) | 1 | 1 | 1 | 1 | 3 |
Pre-tax income (INR Cr) | 3 | 9 | 11 | 14 | 44 |
Net income (INR Cr) | 1.8 | 7.3 | 8.4 | 11.01 | 34.98 |
EPS basic (INR, split-adjusted) | 0.72 | 2.90 | 3.35 | 4.37 | 11.28 |
EPS diluted (INR, split-adjusted) | 0.72 | 2.90 | 3.35 | 4.37 | 11.28 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EBITDA margin (%) | 10 | 14 | 16 | 14.24 | 9.66 |
Operating EBIT margin (%) | 4.1 | 8.6 | 10.3 | 8.2 | 7.4 |
Net margin (%) | 2.5 | 6.3 | 7.2 | 6.11 | 5.76 |
Effective tax rate (%) | 33 | 22 | 26 | 22 | 21 |
Income Statement and Margin Analysis (%)
| Metric | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|
Revenue (INR Cr) | 102.74 | 125.24 | 120.97 | 163.95 | 197.59 | 276.33 |
EBITDA (INR Cr) | 11.40 | 11.62 | 11.67 | 15.26 | 20.14 | 22.59 |
EBITDA margin (%) | 11.09 | 9.28 | 9.65 | 9.31 | 10.19 | 8.18 |
PAT (INR Cr) | 6.44 | 6.52 | 6.95 | 9.41 | 12.10 | 15.04 |
PAT margin (%) | 6.27 | 5.21 | 5.75 | 5.74 | 6.12 | 5.44 |
EPS basic (INR) | 2.56 | 2.41 | 2.24 | 3.03 | 3.90 | 4.85 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 52 | 60 | 68 | 158 | 324 |
Net fixed assets (INR Cr) | 25 | 28 | 38 | 61 | 101 |
Capital work in progress (INR Cr) | 0 | 0 | 0 | 7 | 11 |
Total borrowings (INR Cr) | 11 | 10 | 7 | 43 | 47 |
Shareholders equity (INR Cr) | 23 | 30 | 39 | 52 | 185 |
Equity share capital (INR Cr) | 5 | 5 | 5 | 5 | 6 |
Other assets mainly current (INR Cr) | 28 | 32 | 30 | 90 | 212 |
Other liabilities mainly current (INR Cr) | 18 | 19 | 22 | 64 | 92 |
Approx net working capital (INR Cr) | 10 | 13 | 8 | 26 | 120 |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (INR Cr) | 7 | 11 | 21 | 0 | -34 |
Investing cash flow (INR Cr) | -8 | -9 | -18 | -27 | -56 |
Financing cash flow (INR Cr) | 1 | -2 | -4 | 33 | 99 |
Capex derived (INR Cr) | 8 | 9 | 17 | 21 | 58 |
Free cash flow (INR Cr) | -1 | 2 | 4 | -21 | -92 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
CFO to EBITDA (%) | 105 | 84 | 128 | 13 | -43 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) | 8 | 28 | 24 | 24 | 30 |
ROA (%) | 3.6 | 13.0 | 13.2 | 9.7 | 14.5 |
ROCE (%) | 11 | 28 | 28 | 22 | 29 |
Debt to equity (x) | 0.48 | 0.33 | 0.18 | 0.83 | 0.25 |
Gross debt to EBITDA (x) | 1.6 | 0.6 | 0.4 | 1.7 | 0.8 |
Interest coverage EBIT to interest (x) | 3 | 10 | 12 | 15 | 15 |
Asset turnover (x) | 1.5 | 2.1 | 1.8 | 1.6 | 2.5 |
Debtor days | 76 | 62 | 53 | 73 | 30 |
Inventory days | 174 | 101 | 109 | 151 | 73 |
Payable days | 300 | 202 | 254 | 264 | 72 |
Cash conversion cycle (days) | -49 | -38 | -92 | -40 | 31 |
Working capital days | 25 | 21 | 9 | 16 | 54 |
Revenue by Region
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
India revenue (INR Cr) | 117 | 180.16 | 607.75 |
Production state
| Production state | Plant(s) | Segment(s) | Q1 FY27 revenue (INR Cr) | Share of Q1 FY27 revenue |
|---|---|---|---|---|
Uttarakhand (Roorkee) | Soap, noodle and toothpaste plant | FMCG | 115.12 | 41.7% |
Rajasthan (Bhilwara) | Home care/detergent; edibles; textile process house | FMCG + Textile | 97.55 (71.32 FMCG + 26.23 textile) | 35.3% |
Assam (Guwahati) | Soap noodles + cosmetics | FMCG | 63.90 | 23.1% |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Last close | ₹364 (16 Oct 2026) | Screener |
52-week high / low | ₹394 / ₹201 | Screener |
1-year return | +41% | Screener |
3-year price CAGR | 143% (about 14x) | Screener |
5-year price CAGR | 134% | Screener |
10-year price CAGR | 41% | Screener |
Market cap | About ₹1,127 crore | Screener |
Liquidity | Thinly traded. BSE group "X". Daily volumes are typically a few thousand shares (e.g., 3,880 on 4 Sep 2026). | Accord Fintech; Google Finance |
Share Price
| Price point | Apr2024 | Nov2024 | Dec2024 | Jan2026 | Oct2026 |
|---|---|---|---|---|---|
Share price split-adjusted (INR) | 30.7 | 74.1 | 148.0 | 207.5 | 364.0 |
Valuation Multiples
| Multiple | Sunrakshakk | Banswara Syntex |
|---|---|---|
P/E trailing (x) | 25.9 | 23.4 |
EV/EBITDA trailing (x) | 16.7 | — |
EV/Sales trailing (x) | 1.5 | — |
P/B (x) | 6.1 | 0.8 |
Capital Markets
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Dividend payout (%) | 0 | 0 | 0 | 0 | 0 |
Buyback (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Action by Date
| Date | Action | Detail |
|---|---|---|
30 May 2025 | Preferential allotment | 11,69,600 shares at ₹840 (₹10 face value + ₹830 premium) to promoter and non-promoter groups. Gross proceeds: about ₹98.25 crore by arithmetic; the company cites ₹98.65 crore raised; the EGM approval cap was ₹98.75 crore. The figures differ slightly. |
17 Oct 2025 | Sub-division | 1 share of ₹10 split into 5 shares of ₹2 |
Credit Ratings
| Agency | Rating | Outlook | Instrument | Date |
|---|---|---|---|---|
CRISIL | B (Issuer Not Cooperating) | Stable | Cash credit ₹7.5 crore; term loan ₹1.5 crore (₹9 crore total) | 8 Jul 2026 (also 30 Apr 2025, 29 Feb 2024, 30 Dec 2022) |
Brickwork Ratings | — | — | Bank facilities | Updates 2 Jun 2023, 12 Jun 2024 |
Moody's / S&P / Fitch | Not rated | — | — | — |
Analyst Conclusions
Management guidance summary
| Item | Guidance |
|---|---|
| FY2027 revenue | ₹900–1,000 crore (implies 48–65% YoY growth) |
| FY2028 revenue | +15–20% over FY2027; aspiration of about ₹1,000 crore, with FMCG about 90% |
| FY2025–FY2029 revenue CAGR | 30–35% |
| PAT margin | About 6% in FY2027; +0.75 to 1.0 pp in FY2028 |
| Capex | Minimal capacity capex for 12–18 months |
| Funding | No new equity raise planned |
| Margin outlook | Input-cost normalisation expected in Q3–Q4 FY27; Q2 FY27 still affected |
Implied FY2027 PAT at the guided margins is about ₹54–60 crore, compared with ₹34.98 crore in FY2026. There is no third-party consensus to compare against.
Bull case
-
Growth is capacity-backed, not speculative. About 20,840 TPM is already installed at 50–55% utilisation, and Q1 FY27 annualises to about ₹1,105 crore. On that run-rate, the FY2027 guide of ₹900–1,000 crore looks conservative.
-
Operating leverage in FMCG. FMCG EBITDA margin rose about 65 bps YoY to 8.55% even during a cost spike. If inputs normalise, consolidated margins could return to about 10%, which supports the ~6–7% PAT-margin target.
-
Re-rating toward contract-manufacturing peers. At about 26x trailing P/E and about 17x EV/EBITDA, with 100%+ growth and ROE of about 30%, sustained delivery could attract institutional ownership. DIIs at 3.95% are an early sign.
Bear case
-
Earnings are not yet cash. FY2026 CFO was −₹34 crore on ₹35 crore of PAT. If working capital keeps rising with revenue, the company may need fresh debt or equity, despite management saying no fundraise is planned.
-
Disclosure and governance quality. Contradictory segment-mix slides, an unreconciled section table, related-party M&A, CRISIL non-cooperation and a media-driven rumour clarification together justify a governance discount.
-
Commoditised, price-taking position. B2B soap noodles, detergents and textile job-work give little pricing power. Q1 FY27 already showed margin erosion of about 200 bps from crude-linked inputs, and larger integrated rivals can undercut on price.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| Q2 FY27 results | About mid-Nov 2026 | Revenue run-rate vs. ₹225–250 crore per quarter needed for the guide; margin recovery from 8.18% |
| H1 FY27 balance sheet and cash flow | Nov 2026 | Inventory and receivables build; any turn to positive CFO |
| Segment-reporting clarity | Each quarter | A reconciled, consistent textile/FMCG split |
| Edibles second shift | FY2027 | Revenue step-up from the Bhilwara edibles plant (about ₹30 crore per quarter now) |
| Guwahati utilisation | FY2027 | Moving from ₹63.9 crore per quarter toward capacity |
| Input costs (palm, LABSA, crude) | Ongoing | Q3–Q4 FY27 normalisation as guided |
| Credit rating | FY2027 | Whether the company resumes cooperation with CRISIL or obtains a fresh rating |
| NSE listing status | Ongoing | Confirmation of the conflicting NSE data |
| Institutional ownership | Quarterly | DII/FII additions beyond 3.95% |
| Dividend initiation | FY2027 AGM | First-ever payout as profits scale |
Analyst verdict
Sunrakshakk Industries is an unusual case. A thirty-year-old Bhilwara textile job-worker has, in less than two years, turned itself into a B2B FMCG manufacturing platform with more than ₹750 crore of trailing revenue. The headline numbers are striking: revenue rose 3.4x in FY2026, Q1 FY27 PAT grew 131%, reported ROE is about 30%, leverage is modest at 0.25x debt to equity, and there is enough installed headroom that guidance of ₹900–1,000 crore for FY2027 looks achievable without new capital. Management has also improved its investor communication, with quarterly decks, recorded calls and explicit targets that it has so far met or exceeded.
The quality of those earnings is still unproven, however. Operating cash flow turned sharply negative in FY2026 as the business moved from the supplier-financed economics of textile job-work to working-capital-heavy commodity FMCG. Margins are thin, at 8–10% EBITDA, and they depend on palm- and crude-linked inputs the company cannot control. Governance signals are mixed: the platform was built on a related-party acquisition, segment disclosures have contradicted each other, CRISIL's rating carries the "Issuer Not Cooperating" tag, and the board is promoter-dominated with a combined Chair/MD role.
At about 26x trailing earnings and about 6x book, the market is already pricing in a good part of the growth story. In our view the stock is a high-risk, execution-dependent compounding candidate. Three things would improve the investment case: (1) positive operating cash flow by FY2027, (2) reconciled segment reporting, and (3) margin recovery toward 10% as inputs normalise. Failure on cash conversion would be the clearest sign that reported profitability overstates the underlying economics. Stance: cautiously constructive on operations, sceptical on governance and cash quality. Monitor Q2 FY27 (Nov 2026) as the next decision point.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Tenure / notes | Age | Education / prior roles | FY2025 remuneration |
|---|---|---|---|---|---|
Prakash Chand Chhabra | Chairman & Managing Director (Executive) | Long-serving promoter; signed results filings through FY2024. Simply Wall St shows CEO tenure of 2.6 years, which probably reflects a redesignation. | About 60 | — | About ₹0.61 crore (₹6.1 million), all salary (Simply Wall St, FY2025) |
Tilok Chand Chhabra | Executive Director, Promoter | Part of the 2007 open-offer acquirer group; co-owner per CRISIL | — | — | — |
Saurabh (Sourabh) Chhabra | Executive Director, Promoter | 2007 acquirer group; spokesperson for the Guwahati plant (Jan 2026); bought 1.8 lakh preferential shares (Jul 2025) | — | — | — |
Aishwarya Tripathi | Independent Non-Executive Director | Recent appointment (date not disclosed) | — | — | Sitting fees not disclosed |
Sandeep Hinger | Independent Non-Executive Director (former) | Formerly with Financial Hospital (finance) | — | Assistant Manager – Finance, Financial Hospital | — |
Ashish Kumar Bagrecha | Company Secretary & Compliance Officer | Signs BSE filings since at least 2023 | — | — | — |
CFO | — | Not publicly disclosed in sources reviewed | — | — | — |
“—” = not publicly disclosed.
Governance Overview
| Attribute | Status |
|---|---|
Chair/CEO separation | No. Prakash Chand Chhabra is both Chairman and MD. |
Executive directors | At least 3, all from the promoter family |
Independent directors | At least 1 named (Aishwarya Tripathi); full count not disclosed in sources reviewed |
Women on board | At least 1 (Aishwarya Tripathi) |
Committees | Audit, Nomination & Remuneration, and Stakeholders' Relationship committees are mandated under the Companies Act and LODR. Composition is not disclosed in sources reviewed. |
Internal auditor | Bal Mukund Kabra (died 7 Jan 2026); successor not disclosed |
Secretarial auditor | A resignation was disclosed under Regulation 30 (date not shown in the source). Successor not disclosed. |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
| 2025 | Prakash Chand Chhabra joins/redesignated as Executive Director & MD | Blinkx notes a new position in 2025 |
| 2025 | "A.K. Spintex Limited Appoints Mr. ..." | Owler headline; details truncated |
7–8 Jan 2026 | Death of the internal auditor disclosed | Regulation 30 |
Feb 2026 | Board and committee changes announced | MarketScreener/S&P CI headline |
Not dated | Secretarial auditor resigned | Sharekhan announcement feed |
Shareholding Trend
| Holder category | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
Promoters (%) | 69.66 | 69.66 | 69.66 | 69.66 | 69.66 |
DIIs (%) | 0.00 | 0.00 | 0.00 | 3.95 | 3.95 |
FIIs (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public (%) | 30.33 | 30.34 | 30.35 | 26.39 | 26.38 |
Number of shareholders | 3,741 | 3,593 | 3,619 | 3,792 | 3,947 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Listed? | Relative positioning |
|---|---|---|---|
Textile processing / Bhilwara cluster | Sangam (India) Ltd | Listed (NSE/BSE) | Much larger integrated yarn, fabric and processing player in Bhilwara |
| — | RSWM Ltd (LNJ Bhilwara Group) | Listed | Large integrated textile player; owns processing capacity |
| — | BSL Ltd | Listed | Bhilwara suiting maker with its own processing |
| — | Banswara Syntex Ltd | Listed | Integrated yarn, fabric and garment maker in Rajasthan; FY2026 revenue ₹1,356 crore |
| — | Maral Overseas Ltd | Listed | LNJ group; yarn, fabric and processing |
| — | Numerous unlisted Bhilwara process houses | Unlisted | Direct job-work competitors on price and turnaround |
FMCG contract manufacturing | Hindustan Foods Ltd | Listed | India's leading diversified FMCG contract manufacturer; FY2026 total income ₹4,264.7 crore |
| — | Fena (P) Ltd, RSPL Group | Unlisted | Large detergent and soap manufacturers (own brands plus contract) |
| — | Jyothy Labs Ltd | Listed | Branded home and personal care; buys or makes soaps and detergents; FY2026 revenue ₹2,944 crore |
Soap noodles / oleochemicals | Godrej Industries (Chemicals) | Listed | Major Indian oleochemicals and soap-noodle producer |
| — | VVF India, 3F Industries, AWL Agri Business (soap noodles) | Mixed | Large-scale noodle suppliers with oils-to-noodles integration |
Edibles (savouries/spices) | Bikaji Foods, Gopal Snacks, Prataap Snacks; MDH, Everest (spices) | Mixed | Branded scale players. Sunrakshakk competes at the regional, small-scale end. |
Peer Comparison FY2026
| Metric (FY2026) | Sunrakshakk | Hindustan Foods | Jyothy Labs | Banswara Syntex |
|---|---|---|---|---|
Revenue (INR Cr) | 607.75 | 4,251 | 2,944 | 1,356 |
Revenue growth YoY (%) | 237 | 19.3 | 3.5 | 4.9 |
EBITDA margin (%) | 9.66 | 8.55 | — | 10.5 |
Operating margin (%) | 7.4 | 6.4 | 13.5 | 5.6 |
Net margin (%) | 5.76 | 3.5 | 11.3 | 2.0 |



